Current therapeutic molecules and targets in neurodegenerative diseases based on in silico drug design
2018
Abstract: Background
As the number of elderly persons increases, neurodegenerative diseases are becoming ubiquitous. There is currently a great need for knowledge concerning management of old-age neurodegenerative diseases; the most important of which are: Alzheimer’s disease, Parkinson’s disease, Amyotrophic Lateral Sclerosis, and Huntington’s disease.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
162
References
15
Citations
NaN
KQI